MILLIPLEX MAP Human Complement Panel 1 - Immunology Multiplex Assay
EMD Millipore’s MILLIPLEX® MAP Complement Panel 1 Magnetic Bead Panel is an 8-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma or culture supernatant samples: Complement 2, Complement C4B, Complement C5, Complement C5a, Complement C9, Adipson/Complement Factor D, Mannose-Binding Lecting (MBL) and Complement Factor I. MILLIPLEX® MAP offers the broadest selection…

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
EMD Millipore’s MILLIPLEX® MAP Complement Panel 1 Magnetic Bead Panel is an 8-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma or culture supernatant samples: Complement 2, Complement C4B, Complement C5, Complement C5a, Complement C9, Adipson/Complement Factor D, Mannose-Binding Lecting (MBL) and Complement Factor I.
MILLIPLEX® MAP offers the broadest selection of analytes across a wide range of disease states and species. Once the analytes of interest have been identified, you can rely on the quality that we build into each kit to produce results you can trust. In addition to the assay characteristics listed in the protocol, other performance criteria evaluated during the validation process include: cross-reactivity, dilution linearity, kit stability, and sample behavior(e.g. detectability and stability). Each panel and kit meets stringent manufacturing criteria to ensure batch-to-batch reproducibility.
Each MILLIPLEX® MAP panel and kit includes:
- Quality controls (QCs) provided to qualify assay performance
- Comparison of standard (calibrator) and QC lots to a reference lot to ensure lot-to-lot consistency
- Optimized serum matrix to mimic native analyte environment
- Detection antibody cocktails designed to yield consistent analyte profiles within panel
EMD Millipore’s MILLIPLEX® MAP Complement Panel 1 Magnetic Bead Panel is part of the most versatile system available for complement factor research. From our single to multiplex biomarker solutions, we partner with you to design, develop, analytically validate and build the most comprehensive library available for protein detection and quantitation.
Brochures
SMCxPRO Immunoassay System: Sensitivity You Can Count On
Your research demands flexibility to move from platform to platform and assay to assay. Using single molecule counting (SMC™) technology, MilliporeSigma offers you the ability to take the analysis of your protein of interest down to femtogram/mL levels using the ultrasensitive protein detection SMCxPRO™ platform. This improved level of sensitivity allows for previously undetectable proteins to now be quantified, including endogenous levels.
Bring Your Biomarkers to Life
Discover the protein detection system that fits your needs.
Correlation of Angiogenesis Biomarkers with Early Metastatic Progression in NSCLC as Determined using a Mulitplexed Immunoassay Kit
This white paper demonstrates the general, practical ability of MILLIPLEX® MAP assay kits to generate data that can directly enhance studies of cancer metastasis.
Reput(Ab)le Cancer-Signaling Antibodies
We’re validated. We’re guaranteed. We’re published. We create the antibodies most cited by the research community. Recognizing both the tremendous opportunities and the challenges facing cancer researchers, EMD Millipore is dedicated to developing and refining tools and technologies for the study of cancer. With EMD Millipore’s comprehensive portfolio of reagents and antibodies, researchers can count on dependable, high-quality solutions for analyzing all the hallmarks of cancer.
Correlation of Angiogenesis Biomarkers with Early Metastatic Progression in NSCLC as Determined using a Mulitplexed Immunoassay Kit
This white paper demonstrates the general, practical ability of MILLIPLEX® MAP assay kits to generate data that can directly enhance studies of cancer metastasis.
Multiplex-Enabled Biomarker Analysis for Improved Monitoring of Lupus Nephritis
Lupus nephritis is an autoimmune condition affecting kidney function in both children and adults. Dr. Eve Smith, a NIHR Clinical Lecturer based at Alder Hey Children’s Hospital in Liverpool, UK discusses the difficulty clinicians have when monitoring the disease using traditional methods in the clinic, and how research into urine biomarker combinations using customized MILLIPLEX® Multiplex Assays powered by Luminex® xMAP technology, helps to save time, cost and amount of sample required to enable better monitoring of the condition.
Discover How Researchers at Rush Medical Center are Developing Novel Diagnostic Tests for Non-Small Cell Lung Cancer
Guest Editor, Yasha Talaga of MilliporeSigma, spoke to lead scientist, Dr Jeffrey Borgia to find out more
Autism Linked to Abnormal Immune Responses of Pregnant Mothers
Learn how the maternal immune profile of mothers can predict neurodevelopmental abnormalities
Discover How Multiplex Assays are Advancing Biomedical Research
Top tips to optimize your analyses








